Your browser doesn't support javascript.
loading
Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison.
Nash, Peter; McInnes, Iain B; Mease, Philip J; Thom, Howard; Hunger, Matthias; Karabis, Andreas; Gandhi, Kunal; Mpofu, Shephard; Jugl, Steffen M.
Afiliação
  • Nash P; University of Queensland, Brisbane, QLD, Australia. drpnash@tpg.com.au.
  • McInnes IB; University of Glasgow, Glasgow, UK.
  • Mease PJ; Swedish Medical Center and University of Washington, Seattle, WA, USA.
  • Thom H; University of Bristol, Bristol, UK.
  • Hunger M; MAPI Group, Munich, Germany.
  • Karabis A; MAPI Group, Houten, The Netherlands.
  • Gandhi K; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Mpofu S; Novartis Pharma AG, Basel, Switzerland.
  • Jugl SM; Novartis Pharma AG, Basel, Switzerland.
Rheumatol Ther ; 5(2): 595, 2018 12.
Article em En | MEDLINE | ID: mdl-29858770
ABSTRACT
Under Methods section, heading Analyses Pairwise Comparisons, one of the probability value was published incorrectly in a sentence. The correct sentence should read as follows.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article